There are basically 2 ways of increasing immune capability– we can either confer“passive immunity” or stimulate“active immunity” . When children nurse breast milk, they receive antibodies from their mother which travel (undigested) into their bloodstream. This confers upon the infant immunity against those germs that the mother is immune to– but only until the child is weaned. This “temporary” immunity is basically being borrowed from someone else, without stimulating the child’s own immune system, and so is called “passive immunity” . If an adult is exposed to Hepatitis-A at an unsanitary restaurant, they go to their doctor for a shot of “gamma globulin” – that is pooled antibody from people who have successfully fought hepatitis- A in the past. This “passive immunity” is enough (if given at the right time) to kill the hepatitis-A germ in our exposed adult. After a few weeks, this temporary immunity will be lost, so if the adult is exposed again they will require another dose of gamma globulin.In contrast, when a child receives vaccinations (e.g. polio, mumps, measles, tetanus) they are being exposed to either a killed germ or a weakened living one. This stimulates their immune system to recognize that germ, and start to produce protective“antibody” against it. The T-helper memory cells can recall for years, or even a decade, what that germ’s protein coat looked like, and what the right antibody was to combat it. Since we are stimulating the child’s own immune system, this defence is called “active immunity”, and will be long-lasting. As adults, if we sustain a deep injury with a soiled object, and we have not had a tetanus shot in ~10 years, we are given “tetanus immune globulin” to confer passive immunity for the current injury, and also “tetanus toxoid” to stimulate active immunity for the future. Thus a person may receive both types of“immune therapy” . Immune therapy may be very “specific”, only meant to combat one type of germ, or it may be “general”, to boost the entire immune system to a higher level of functioning. Adjusting the immune system’s functioning, up or down, is called “immune modulation” . If one removes immune system cells and stimulates them in the laboratory to become more effective against a particular antigen, this is called“Adoptive Immunotherapy” .
Understanding how immune therapy works for germs also helps us understand it’s use for cancer. Passive, Active, and “Adoptive” immunotherapy can be utilized to help cure cancer . An example of using passive immunity would be manufacturing (“cloning”) monoclonal antibodies to a particular cancer’s protein coat, and then injecting them into the patient. These antibodies would (hopefully) gravitate and join exclusively to the tumor cells, and thus be extremely specific. Once coated, the cancer cells would be easily identifiable as foreign to other WBCs, and be quickly destroyed by an “immunocompetent” individual. Eventually the monoclonal antibodies would be all used up, degraded by the liver, or themselves targeted by the immune system as being “foreign”. Since the patient themselves would not produce any more, this would be temporary, passive immunity.
An example of stimulating active immunity is when the BCG vaccine (used as a test for tuberculosis) is injected in the patient– it prompts a strong, non-specific immune response. We are basically flooding the immune system with a foreign antigen, and it gears both to start producing antibody (humoral immunity) and to engulf the foreign antigen by“phagocytosis” (cell eating– cellular immunity). Fluids around the tumor can actually be dranken up by the process of“pinocytosis” (cell drinking). Thus, the immune system cells can literally gobble up the BCG antigen. The patient’s immune system will remember the BCG vaccine, and if it encounters it again will quickly make antibodies to it– thus it is nearly permanent, active immunity (it is “nearly permanent” since eventually the long lived T-memory cells will die off).
The BCG vaccine, used for bladder cancer, is non-specific, but other tumor vaccines are specific for their particular targets. A classic example of this is the “melanoma vaccine”, made up from the TILs of patients who have mounted a successful immune response to melanoma. If this vaccine is then injected into another patient, it can “teach” their immune system how to fight melanoma– this is stimulating active immunity against the melanoma itself. Theoretically, this treatment should have no significant side effects against any normal cell, just boost the immune response (as seen by the TILs around the tumor).
Adoptive Immunotherapy is used when NK cells or TILs are removed from the region of the tumor, and worked with in the laboratoy. They are given “mitogens” which cause them to divide (undergo “clonal expansion”) as well as lymphokines like interleuken-2 to activate them. Once they are plentiful and active, they are injected back into the patients tumor and/or bloodstream, where they will hunt down cancer cells and kill them. This is then using a combination of natural active immunity (the patient’s own response to the tumor) and passive immunity (artificially multiplying and implanting an immune response) to treat cancer.
The main drawback of all of the above therapies is that their effects tend to be temporary and non-curative if used alone.Cancer cells have a nascent genetic “intelligence” which allows them to overcome therapies which should theoretically decimate them . Of course, billions of cancer cells are killed by surgery, radiation, chemotherapy, hormonal therapy, and immunotherapy, but the problem lies with those few that remain, and are the strongest and best able to re-establish the tumor. We previously said that immune therapy is much more successful at killing small numbers of individual cancer cells than attacking large tumors. It is the principle therapy in killing “micrometastasis” of tumors prior to seeding the cancer to distant body areas. The current key to cure cancer is by using MULTI-MODALITY therapy, that is attacking the cancer from many different vantage points simultaneously, not allowing it time to develop resistance. A careful strategy of conventional therapy is required to help ensure that the immune system is not being too supressed to help cure the cancer. No single therapy today cures anything but the earliest cancer . Immunotherapy is crucial in a successful campaign, since it is the ONLY known therapy (within normal tissue tolerance) capable of annihilating the last, stongest, cancer cells.
This is just an excerpt from our Complete Cancer Treatment Transcript. Much more, including latest treatments, can be sent to you by email when you order the complete transcript at a nominal cost.
